Professor at Department of Medical Ultrasound, Shanghai Tenth People’s Hospital, China
Professional Profile
Scopus
🎓Academic and Professional Background
Dr. Yifeng Zhang is a Doctor of Medicine and Professor with nearly 20 years of experience in the field of ultrasound diagnosis and interventional treatment. Specializing in thyroid, breast, and prostate diseases, she has contributed significantly to advancing the use of contrast-enhanced ultrasound, elastography, and ultrasound-related molecular diagnostics. Dr. Zhang has published almost 30 SCI papers and has received funding from national-level research projects, underlining her profound expertise and commitment to innovation in medical ultrasound technology.
🌍Professional Memberships
Dr. Zhang holds several key positions within esteemed medical organizations. She is an active member of the Youth Committee of the Ultrasound Medicine Branch of the Shanghai Medical Association. In addition, she has served as Vice Chairman of multiple influential groups, including the Artificial Intelligence and Remote Ultrasound Group of the Ultrasound Medicine Branch of the Shanghai Medical Association, the Breast Intervention Group of the Ultrasound Intervention Professional Committee of the Chinese Medical Association, and the First Youth Study Group of the Ultrasound Medicine Branch of the Cross-Strait Medical and Health Exchange Association. These leadership roles underscore her dedication to advancing the field of medical ultrasound and shaping its future development.
🔬Areas of Research
Dr. Zhang’s research focuses on the ultrasound diagnosis and interventional treatment of thyroid, breast, and prostate diseases. Notably, she has made pioneering contributions in contrast-enhanced ultrasound and elastography, improving diagnostic accuracy and patient outcomes. Her work in prostate cancer has revolutionized ultrasound, reducing unnecessary prostate punctures from 83.7% to 5.4%, by significantly enhancing ultrasound’s predictive value. Dr. Zhang also innovatively developed a new MRI-guided prostate contrast-enhanced ultrasound, surpassing MRI’s diagnostic ability in certain cases. Furthermore, her groundbreaking work has led to the establishment of diagnostic criteria for elastography, inclusion in international guidelines, and solutions to tumor risk stratification challenges.
Publications Top Noted📚
Can ACR TI-RADS predict the malignant risk of medullary thyroid cancer?
Authors: Zhang, Y., Ye, B.-B., Wang, H.-X., Qin, C., Zhang, Y.-F.
Journal: Journal of Clinical and Translational Endocrinology
Year: 2025
Bacteria-Mediated Tumor-Targeting Delivery of Multienzyme-Mimicking Covalent Organic Frameworks Promoting Pyroptosis for Combinatorial Sono-Catalytic Immunotherapy
Authors: Liu, Y., Xiang, L., Li, Y., Xu, H., Zhang, Y.
Journal: Advanced Science
Year: 2024
Imprinted gene detection effectively improves the diagnostic accuracy for papillary thyroid carcinoma
Authors: Chen, Y., Yin, M., Zhang, Y., Min, X., Chen, B.
Journal: BMC Cancer
Year: 2024
Exploiting a tumor softening targeted bomb for mechanical gene therapy of chemoresistant Triple-Negative breast cancer
Authors: Shen, Y., Guan, X., Li, S., Xu, H., Yue, W.
Journal: Chemical Engineering Journal
Year: 2024
Predicting tall-cell subtype of papillary thyroid carcinomas independently with preoperative multimodal ultrasound
Authors: Ye, B.-B., Liu, Y.-Y., Zhang, Y., Zhang, Y.-F., Xu, H.-X.
Journal: The British Journal of Radiology
Year: 2024